Results 71 to 80 of about 58,718,765 (142)

[ANALYSIS OF FACTORS INVOLVED IN THE DEVELOPMENT OF HUMORAL RESPONSE TO VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH RHEUMATIC PATHOLOGY UNDER BIOLOGICAL TREATMENT.] [PDF]

open access: yesReumatol Clin, 2023
Flores-Fernández E   +5 more
europepmc   +1 more source

Methylome and transcriptome profiling of giant cell arteritis monocytes reveals novel pathways involved in disease pathogenesis and molecular response to glucocorticoids. [PDF]

open access: yesAnn Rheum Dis, 2022
Estupiñán-Moreno E   +12 more
europepmc   +1 more source

Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing. [PDF]

open access: yesAnn Rheum Dis, 2023
Ortiz-Fernández L   +24 more
europepmc   +1 more source

[Adaptation of headache units in Andalusia to the COVID-19 pandemic. Analysis of the Andalusian Neurology Society's Headache Study Group]. [PDF]

open access: yesRev Neurol, 2022
Lamas-Pérez R   +5 more
europepmc   +1 more source

COVID-19: Overview of rheumatology fellows. [PDF]

open access: yesReumatol Clin (Engl Ed), 2021
Garcia-Guillén A   +3 more
europepmc   +1 more source

Tocilizumab for giant cell arteritis. [PDF]

open access: yesCochrane Database Syst Rev, 2022
Antonio AA, Santos RN, Abariga SA.
europepmc   +1 more source

Estudio descriptivo de la arteritis de células gigantes en el Hospital Universitario Donostia con especial énfasis en los problemas oculares

open access: yes, 2019
[ES] La arteritis de células gigantes (ACG), también conocida como arteritis de la temporal o arteritis de Horton, es una vasculitis crónica de vasos medios y grandes que ocurre entre las personas mayores de 50 años de edad, pudiendo causar ...
Moreno Benito, Naroa
core  

Endovascular treatment in Behçet's disease: an integrative review. [PDF]

open access: yesJ Vasc Bras, 2022
Dumont LS   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy